Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease
- PMID: 11036119
- DOI: 10.1056/NEJM200010193431602
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease
Abstract
Background: In patients with unstable coronary artery disease, there is a relation between the short-term risk of death and blood levels of troponin T (a marker of myocardial damage) and C-reactive protein and fibrinogen (markers of inflammation). Using information obtained during an extension of the follow-up period in the Fragmin during Instability in Coronary Artery Disease trial, we evaluated the usefulness of troponin T, C-reactive protein, and fibrinogen levels and other indicators of risk as predictors of the long-term risk of death from cardiac causes.
Methods: Levels of C-reactive protein and fibrinogen at enrollment and the maximal level of troponin T during the first 24 hours after enrollment were analyzed in 917 patients included in a clinical trial of low-molecular-weight heparin in unstable coronary artery disease. The patients were followed for a mean of 37.0 months (range, 1.6 to 50.6).
Results: During follow-up, 1.2 percent of the 173 patients with maximal blood troponin T levels of less than 0.06 microg per liter died of cardiac causes, as compared with 8.7 percent of the 367 patients with levels of 0.06 to 0.59 microg per liter and 15.4 percent of the 377 patients with levels of at least 0.60 microg per liter (P=0.007 and P=0.001, respectively). The rates of death from cardiac causes were 5.7 percent among the 314 patients with blood C-reactive protein levels of less than 2 mg per liter, 7.8 percent among the 294 with levels of 2 to 10 mg per liter, and 16.5 percent among the 309 with levels of more than 10 mg per liter (P=0.29 and P=0.001, respectively). The rates of death from cardiac causes were 5.4 percent among the 314 patients with blood fibrinogen levels of less than 3.4 g per liter, 12.0 percent among the 300 with levels of 3.4 to 3.9 g per liter, and 12.9 percent among the 303 with levels of at least 4.0 g per liter (P=0.004 and P=0.69, respectively). In a multivariate analysis, levels of troponin T and C-reactive protein were independent predictors of the risk of death from cardiac causes.
Conclusions: In unstable coronary artery disease, elevated levels of troponin T and C-reactive protein are strongly related to the long-term risk of death from cardiac causes. These markers are independent risk factors, and their effects are additive with respect to each other and other clinical indicators of risk.
Comment in
-
Inflammatory markers of coronary risk.N Engl J Med. 2000 Oct 19;343(16):1179-82. doi: 10.1056/NEJM200010193431609. N Engl J Med. 2000. PMID: 11036126 No abstract available.
-
Markers of myocardial damage and inflammation in unstable coronary artery disease.N Engl J Med. 2001 Mar 1;344(9):688-9. doi: 10.1056/NEJM200103013440915. N Engl J Med. 2001. PMID: 11229340 No abstract available.
Similar articles
-
The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.N Engl J Med. 1994 Aug 18;331(7):417-24. doi: 10.1056/NEJM199408183310701. N Engl J Med. 1994. PMID: 7880233
-
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.N Engl J Med. 1995 Mar 9;332(10):635-41. doi: 10.1056/NEJM199503093321003. N Engl J Med. 1995. PMID: 7845427 Clinical Trial.
-
[Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice].Lakartidningen. 2004 Apr 22;101(17):1514-9, 1521-2. Lakartidningen. 2004. PMID: 15150954 Clinical Trial. Swedish.
-
C-reactive protein increase in unstable coronary disease cause or effect?J Am Coll Cardiol. 2005 Oct 18;46(8):1496-502. doi: 10.1016/j.jacc.2005.05.083. Epub 2005 Sep 28. J Am Coll Cardiol. 2005. PMID: 16226174 Review.
-
Low-molecular-weight heparin as a bridge to timely revascularization in unstable coronary artery disease -- an update of the Fragmin during Instability in Coronary Artery Disease II Trial.Haemostasis. 2000;30 Suppl 2:108-13; discussion 106-7. doi: 10.1159/000054175. Haemostasis. 2000. PMID: 11251353 Review.
Cited by
-
Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography.Atherosclerosis. 2015 Mar;239(1):268-75. doi: 10.1016/j.atherosclerosis.2015.01.003. Epub 2015 Jan 14. Atherosclerosis. 2015. PMID: 25635325 Free PMC article.
-
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.J Am Heart Assoc. 2016 May 20;5(5):e002586. doi: 10.1161/JAHA.115.002586. J Am Heart Assoc. 2016. PMID: 27207959 Free PMC article.
-
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).BMJ. 2006 Nov 25;333(7578):1091. doi: 10.1136/bmj.38985.646481.55. Epub 2006 Oct 10. BMJ. 2006. PMID: 17032691 Free PMC article.
-
A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease.Clin Cardiol. 2001 Jul;24(7):492-9. doi: 10.1002/clc.4960240715. Clin Cardiol. 2001. PMID: 11444639 Free PMC article.
-
Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.Circ Res. 2014 May 23;114(11):1733-42. doi: 10.1161/CIRCRESAHA.114.303454. Epub 2014 Mar 19. Circ Res. 2014. PMID: 24647144 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials